AdvisorShares Psychedelics ETF (PSIL)

NYSEARCA: PSIL · Real-Time Price · USD
8.00
-0.03 (-0.37%)
Sep 18, 2024, 4:00 PM EDT - Market closed
-0.37%
Assets $4.53M
Expense Ratio 0.99%
PE Ratio n/a
Shares Out 579,976
Dividend (ttm) $0.00
Dividend Yield 0.04%
Ex-Dividend Date Sep 25, 2023
Payout Ratio n/a
1-Year Return -53.75%
Volume 11,346
Open 8.08
Previous Close 8.03
Day's Range 7.84 - 8.08
52-Week Low 0.88
52-Week High 17.60
Beta 0.89
Holdings 27
Inception Date Sep 15, 2021

About PSIL

Fund Home Page

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is issued by AdvisorShares.

Asset Class Equity
Category Miscellaneous Sector
Stock Exchange NYSEARCA
Ticker Symbol PSIL
ETF Provider AdvisorShares

Top 10 Holdings

66.48% of assets
Name Symbol Weight
Mind Medicine (MindMed) Inc. MNMD 14.77%
COMPASS Pathways plc CMPS 8.25%
Cybin Inc. CYBN 7.94%
BlackRock Liquidity Treasury Instl TTTXX 7.15%
Incannex Healthcare Inc. IXHL 4.99%
Alkermes plc ALKS 4.91%
Bright Minds Biosciences Inc. DRUG 4.85%
GH Research PLC GHRS 4.55%
Vistagen Therapeutics, Inc. VTGN 4.54%
Clearmind Medicine Inc. CMND 4.51%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Sep 25, 2023 $0.003 Sep 29, 2023
Sep 26, 2022 $0.5421 Sep 30, 2022
Full Dividend History

News

AdvisorShares Announces Reverse Split of ETF

BETHESDA, Md. , Aug. 30, 2024 /PRNewswire/ -- AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), has announced a reverse split of the issued and outstanding shares of t...

19 days ago - PRNewsWire

EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics - AdvisorShares Psychedelics ETF (ARCA:PSIL)

The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space.

1 year ago - Benzinga

Cannabis Is A Psychedelic - Dr. Julie Holland

Dr. Julie Holland on why cannabis is a psychedelic. The biggest risk in psychedelic treatment.

1 year ago - Seeking Alpha

PSIL: When Investing In Psychedelic Firms, ETFs Are The Safer Route

There have been some exciting developments in the research around the medicinal potential of psychedelic compounds. Despite a potential opportunity for disruption, investors should keenly understand t...

1 year ago - Seeking Alpha

The Growth Potential Of Psychedelics Stocks And ETFs

On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan...

Other symbols: ATAICMPSCYBNMNMDSEEL
2 years ago - Seeking Alpha